
Archived App (Last seen on 21 Sep 2026)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
This Immersive Enhanced Reality experience explores the rationale behind using disease-modifying therapies (DMTs) to delay the progression of type 1 diabetes (T1D), along with key considerations for applying these therapies in patient care. The activity will provide an overview of the criteria for identifying eligible patients who may benefit from these therapies, as well as important considerations for dosing and administration strategies. The goal is to support the integration of DMTs into care plans to delay T1D progression and optimize treatment outcomes.
Show more
What's New in Application of DMTs for T1D
1.2.9
August 22, 2026
New app content.



